Enveric Biosciences Inc (FRA:SLZA)
€ 0.4755 -0.004 (-0.83%) Market Cap: 4.13 Mil Enterprise Value: -2.40 Mil PE Ratio: 0 PB Ratio: 0.78 GF Score: 54/100

Enveric Biosciences Inc at H.C. Wainwright Neuropsychiatry Virtual Conference Transcript

Jun 26, 2023 / 11:00AM GMT
Release Date Price: €3.39 (-0.15%)
Brooke Katsof
H.C. Wainwright & Co., LLC - Analyst

Good morning, everyone, and thank you for joining the H.C. Wainwright Fourth Annual Meeting Neuropsychiatry Virtual Conference taking place on June 26, 2023. My name is Brooke Katsof, and I'm an H.C. Wainwright analyst.

H.C. Wainwright is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sites for publishing. Senior analysts in over 648 companies covered across all sectors. Please visit hcwco.com for more information.

Please join us for a one-on-one meeting corporate presentations and panels that will be available live and streaming on June 26. With that said, have a productive and enjoyable day. And I'd like to introduce our first presenter. I'd like to welcome Joseph Tucker, who is the CEO of Enveric Biosciences.

Joseph Tucker
Enveric Biosciences, Inc. - CEO & Director

Thank you, Brooke. I appreciate that introduction, and hi, everyone. As Brooke said, I'm Dr. Joseph

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot